Nuo Therapeutics Files 2024 10-K, Notes March 2025 Agreement
Ticker: AURX · Form: 10-K · Filed: Apr 1, 2025 · CIK: 1091596
| Field | Detail |
|---|---|
| Company | Nuo Therapeutics, Inc. (AURX) |
| Form Type | 10-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, subsequent-event, distribution-agreement
TL;DR
Nuo Therapeutics 2024 10-K is in. Big distribution deal signed March 31, 2025.
AI Summary
Nuo Therapeutics, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as CytomediX Inc., is based in Houston, TX. A significant subsequent event noted is a Distribution Agreement entered into on March 31, 2025.
Why It Matters
This filing provides a comprehensive overview of Nuo Therapeutics' financial health and operational status for 2024, including a key distribution agreement signed in early 2025 that could impact future revenue streams.
Risk Assessment
Risk Level: medium — The company has undergone name changes and its business operations are subject to the inherent risks of the medical instruments and apparatus industry.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-04-01 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Nuo Therapeutics, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-04-01 (date) — Filing date
- Houston, TX (location) — Company business address
- CytomediX Inc. (company) — Former company name
- 2025-03-31 (date) — Date of Distribution Agreement
FAQ
What is the nature of the Distribution Agreement entered into on March 31, 2025?
The filing indicates a 'DistributionAgreementMember' as a subsequent event on March 31, 2025, but does not provide specific details on the nature of the agreement within the provided text.
What were Nuo Therapeutics' previous names?
Nuo Therapeutics, Inc. was formerly known as CytomediX Inc. (name change effective 2000-05-11) and Autologous Wound Therapy Inc. (name change effective 2000-04-07).
What is Nuo Therapeutics' primary industry classification?
Nuo Therapeutics, Inc. is classified under SURGICAL & MEDICAL INSTRUMENTS & APPARATUS with the SIC code 3841.
When did Nuo Therapeutics' fiscal year 2024 end?
Nuo Therapeutics' fiscal year 2024 ended on December 31, 2024.
Where is Nuo Therapeutics, Inc. headquartered?
Nuo Therapeutics, Inc. is headquartered at 8285 El Rio, Suite 150, Houston, TX 77054.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 1, 2025 regarding Nuo Therapeutics, Inc. (AURX).